78 TH SCIENTIFIC SESSIONS PRODUCT THEATER SCHEDULE SATURDAY, JUNE 23, 2018
|
|
- Anis Sanders
- 5 years ago
- Views:
Transcription
1 78 TH SCIENTIFIC SESSIONS PRODUCT THEATER SCHEDULE Product Theaters, located within the Exhibit Hall, offer informative sessions focusing on products or a single facet of diabetes. Product Theater sessions do not provide continuing education credit. These sessions are intended for health care professionals only with practices relevant to the presented information. Light refreshments provided by the ADA will be served to the first 300 attendees. SATURDAY, JUNE 23, 2018 Continuous Glucose Monitoring Reinvented Introducing the FreeStyle Libre System Presented by Abbott Introducing the FreeStyle Libre System. Simple accurate, 1 and more affordable* continuous glucose monitoring for your patients. 1. FreeStyle Libre User s Manual. * Based on the manufacturer s list price of the FreeStyle Libre system. The actual cost to you may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any. Presenters: W. Reid Litchfield, MD, FACE, ECNU, FRCP Desert Endocrinology Nevada Thyroid Institute Henderson, NV Special Guest Speaker Cardiovascular Disease Burden in the U.S. and Clinical Evaluation of VASCEPA (Icosapent Ethyl) Presented by Amarin Pharma, Inc. Hear from an expert about cardiovascular disease burden in the U.S. and clinical evaluation of VASCEPA (icosapent ethyl). Despite the benefits of LDL-C lowering, many patients on statin therapy remain at risk. In this presentation, new data and perspectives on the role of high triglycerides as a marker of increased cardiovascular risk in patients with statin-controlled LDL-C will be discussed. The clinical development program and safety for pure EPA VASCEPA will be reviewed. Eliot A. Brinton, MD President Utah Lipid Center Salt Lake City, UT
2 Introducing a New Era in Glucose Monitoring The Eversense Continuous Glucose Monitoring System Presented by Senseonics The world s first long-term implantable continuous glucose monitoring system. Based on novel fluorescence technology, Eversense provides continuous real-time readings up to 3 months with a single sensor. Get a first look at the product technology, which includes a wearable smart transmitter that can be taken on or off and provides discreet vibratory glucose alerts. Learn about the clinical performance resulting in sustained accuracy over the 3-month wear period. During this session, you will hear from clinicians and patients discussing firsthand experience with the technology. At the conclusion of the presentations, there will be a Q&A session. You don t want to miss this panel of industry experts and current Eversense users! Presenters: E. Lynne Kelley, MD, FACS Chief Medical Officer Senseonics, Inc Germantown, MD Timothy S. Bailey, MD, FACE, FACP, CPI President and CEO AMCR Institute, Inc. Escondido, CA Jenine Yager Stone, MSN, FNP-C Assistant Director, Clinical Research AMCR Institute, Inc. Escondido, CA 12:15 p.m.-1:15 p.m. Jardiance (Empagliflozin) Tablets Evolving Clinical Development Presented by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA This program will discuss recent data from the ongoing Jardiance clinical development program. The presentation will cover efficacy and safety data, as well as the dosing information for Jardiance. Attendees will also have the opportunity to ask the faculty questions about the data presented. Presenters: Leigh Perreault, MD Associate Professor of Medicine Division of Endocrinology, Metabolism, and Diabetes Affiliate Center for Global Health University of Colorado Anschutz Medical Campus Associate Professor of Epidemiology Colorado School of Public Health Boulder, CO Pam R. Taub, MD, FACC Associate Professor of Medicine University of California, San Diego Health System San Diego, CA
3 12:15 p.m.-1:15 p.m. The Role of GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Management Presented by AstraZeneca Pharmaceuticals This presentation will review the important role of glucagon-like peptide-1 (GLP-1) in physiologic glucose regulation and the mechanism of GLP-1 receptor agonists in addressing the core defects of type 2 diabetes. The clinical efficacy, safety, and potential place in therapy of a once-weekly, GLP-1 receptor agonist, prefilled autoinjector will be discussed. In addition, there will be a live demonstration of the autoinjector. Robert S. Busch, MD Albany Medical College Albany, NY 12:15 p.m.-1:15 p.m. Developments in GLP-1 Treatment Options for Adults with Type 2 Diabetes Presented by Novo Nordisk A/S James R. Gavin III, MD, PhD Clinical Professor of Medicine Emory University School of Medicine Chief Medical Officer Healing Our Village, Inc. Atlanta, GA 2:45 p.m.-3:30 p.m. Evaluating the Impact of a Safety Outcomes Trial Incidence of Major Adverse Cardiovascular Events and Clinical Importance of Severe Hypoglycemia for Type 2 Diabetes Patients Requiring a Long-Acting Insulin Presented by Novo Nordisk A/S Helena W. Rodbard, MD, FACP, MACE Medical Director Endocrine and Metabolic Consultants Rockville, MD
4 2:45 p.m.-3:30 p.m. Introducing the New Dexcom G6 Simple, Accurate, Effective Presented by Dexcom Introduction and Review of the new Dexcom G6 Continuous Glucose Monitoring System. Dexcom G6 CGM technology, features, accuracy, usability and product enhancement. Dexcom G6 pivotal trial data, patient experience, and training best practices. Presenters: Jake Leach Senior Vice President, Research and Development Dexcom San Diego, CA Keri Leone, MS, RD, CDE Senior Director, Global Professional Education Dexcom San Diego, CA R. Paul Wadwa, MD Associate Professor of Pediatrics University of Colorado School of Medicine Director of Telemedicine Medical Director, Pediatric Clinic, Barbara Davis Center for Childhood Diabetes Aurora, CO CT THEATERS
5 SUNDAY, JUNE 24, 2018 Praluent (Alirocumab) Injection The Time to Treat Is Now Presented by Sanofi-Regeneron Kenneth Feingold, MD Professor of Medicine University of California, San Francisco San Francisco, CA Criticality of LDL-C Lowering in Patients with Diabetes Mellitus Presented by Amgen Paul S. Jellinger, MD, MACE Professor of Clinical Medicine University of Miami Miller School of Medicine The Center for Diabetes and Endocrine Care Ft. Lauderdale, FL The Guardian Connect Continuous Glucose Monitoring System Utilizing Predictive Alerts and Data Backed Insights to Help with Diabetes Management Presented by Medtronic Please join us and learn how predictive alerts and data backed insights of the Guardian Connect Smart CGM system can help you and your patients with diabetes management. Presentation will include a system overview, real-world data, case studies, and best practices. Presenters: Timothy S. Bailey, MD, FACE, CPI President & CEO, AMCR Institute, Inc. Clinical Associate Professor of Medicine University of California, San Diego Escondido, CA Huzefa Neemuchwala, PhD, MBA Senior Director, Data and Digital Information Medtronic Diabetes Northridge, CA
6 12:30 p.m.-1:30 p.m. Pneumococcal Disease in Adults Aged <65 Years with Diabetes or Other Select Chronic Conditions Presented by Merck & Co., Inc. Describe pneumococcal disease in adults aged <65 years with diabetes or other select chronic conditions. Review CDC recommendations for pneumococcal vaccination in this population. PNEUMOVAX 23 pneumococcal disease vaccine (pneumonia, meningitis, bacteremia). PRODUCT THEATERS 12:20 p.m.-1:30 p.m. Improving Glycemic Control in Type 1 Diabetes The Role of Insulin-Independent Pathways Presented by Lexicon Pharmaceuticals and Sanofi Yehuda Handelsman, MD, FACP, FNLA, MACE Medical Director & Principal Investigator Metabolic Institute of America Tarzana, CA 12:30 p.m.-1:30 p.m. Severe Hypertriglyceridemia and Pancreatitis Including Familial Chylomicronemia Syndrome (FCS) in Your Differential Diagnosis Presented by Akcea Therapeutics This program provides clinicians with information on Familial Chylomicronemia Syndrome (FCS), a disease in which inherited defects result in the accumulation of chylomicrons in the plasma causing acute pancreatitis and sequelae which can impact daily life including recurrent pain, recurrent acute pancreatitis, and permanent pancreatic damage. Is a patient like this in your practice? Severe, refractory hypertriglyceridemia o TG>880 mg/dl o Not responsive to standard triglyceride-lowering therapies No secondary causes of hypertriglyceridemia One or more of: o History of pancreatitis o History of recurrent abdominal pain without other explainable cause Objectives for attending clinicians include: Differentiate the FCS patient from patients with secondary causes of hypertriglyceridemia Appreciate the importance of FCS diagnosis Understand the value of connecting FCS patients to educational resources and the FCS patient community Richard L. Dunbar, MD Perelman School of Medicine University of Pennsylvania Philadelphia, PA
7 3:00 p.m.-3:45 p.m. Basal Insulin Treatment Considerations in Adult Patients with Type 2 Diabetes Mellitus Presented by Sanofi Carol H. Wysham, MD Clinical Professor of Medicine University of Washington Spokane, WA 3:00 p.m.-3:45 p.m. Closing the Loop with Blood Glucose Meters Supporting Current Continuous Glucose Monitoring and Future Therapies Presented by Ascensia Diabetes Care As diabetes management solutions continue to evolve, for all people with diabetes, the use of Blood Glucose Meters (BGM) play an integral role in supporting other technologies such as Continuous Glucose Monitors (CGM), Flash Glucose Monitors (FGM), Hybrid Closed-Loop System (HCLS) (such as the Medtronic MiniMed 670G), and Artificial Pancreas Device Systems (APDS). This session will discuss these technologies and the role of BGM within each. Steven Edelman, MD Division of Endocrinology and Metabolism University of California, San Diego Founder/Director Taking Care Of Your Diabetes (TCOYD) San Diego, CA PRODUCT THEATERS
8 MONDAY, JUNE 25, 2018 MiniMed 670G System Increasing Time In Range with Automated Insulin Delivery Presented by Medtronic Please join us and learn how the MiniMed 670G system has changed the way we are managing time in range for patients with type 1 diabetes. Presentation will include real-world data, case studies, and best practices. Presenters: Jennifer Sherr, MD, PhD Pediatric Endocrinologist, Associate Professor Yale School of Medicine New Haven, CT Anders L. Carlson, MD Medical Director International Diabetes Center at Park Nicollet Minneapolis, MN Repatha (Evolocumab) Putting It into Practice Presented by Amgen Join Eliot A. Brinton, MD, FAHA, FNLA, as he conducts an educational presentation on the importance of Repatha (evolocumab). Hear about his experience with Repatha and the options available for appropriate patients. Eliot A. Brinton, MD, FAHA, FNLA President Utah Lipid Center Salt Lake City, UT DCT THEATERS 12:30 p.m.-1:30 p.m. The Omnipod DASH System Simplifying Insulin Delivery for Your Patients and Practice Presented by Insulet Corporation Learn how the Omnipod DASH Insulin Management System will build on the simplicity and ease-ofuse of the existing Omnipod System platform leveraging its tubeless, waterproof design to address the needs of people with insulin-dependent diabetes. The Omnipod DASH System includes the Pod that will remain unchanged in size with Bluetooth technology for greater connectivity to the Personal Diabetes Manager (PDM) as well as to the compatible Contour NEXT One Blood Glucose (BG) Meter. The new, slimmer PDM will feature a color touchscreen interface and will enable discreet insulin delivery with a few finger taps. A new suite of ios mobile applications will give users and their caregivers quick and easy access to their insulin therapy information on their smartphones. The Omnipod DASH system will also be compatible with Insulet Provided Glooko for easy data upload, improved care team collaboration, and access to meaningful data context which will allow for informed diabetes management decisions. Come to our Product Theater to learn more about the Omnipod DASH System and Insulet s commitment to reducing the burden of diabetes for health care providers, users, and their caregivers. Caution: Pending 510(k) clearance. Not available for sale in the U.S.
9 Presenters: Trang Ly, MBBS, FRACP, PhD Senior Vice President and Medical Director Insulet Corporation Billerica, MA Daniel DeSalvo, MD Assistant Professor of Pediatrics of Diabetes & Endocrinology Baylor College of Medicine/Texas Children s Hospital Houston, TX 12:30 p.m.-1:30 p.m. A Treatment Option for Adults with Type 2 Diabetes Presented by Merck & Co., Inc. Review select prescribing information for a type 2 diabetes therapeutic option. Lance Sloan, MD, FACE, FASN Private Practice Lufkin, TX
Product Theaters. Light refreshments provided by the American Diabetes Association will be served to the first 300 attendees.
Product Theaters Product Theaters, located in the rear of the Exhibit Hall, offer informative sessions focusing on particular products or a single facet of diabetes. Product Theater sessions do not provide
More informationInsulin Pumps and Continuous Glucose Sensors- Embracing Technology. Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education
Insulin Pumps and Continuous Glucose Sensors- Embracing Technology Susan Cavalier, BS, RN, CDE Manager, Diabetes Educator Sanford Diabetes Education Diabetes Management Tools in 1974 Insulin pump history
More informationDiabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018
Diabetes Technology Update Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018 Disclosures None No future technologies are FDA approved Continuous Glucose Monitors Continuous Glucose Monitors
More informationFlash Glucose Monitoring & Implantable Sensors
Flash Glucose Monitoring & Implantable Sensors Timothy Bailey, MD, FACE, CPI President & CEO, AMCR Institute Clinical Associate Professor, UCSD School of Medicine Disclosures Research Support: Abbott,
More informationNEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP
NEW TECHNOLOGIES FOR MANAGING DIABETES ANGELA THOMPSON DNP, FNP-C, BC-ADM, CDE, FAANP No commercial support or sponsorship was received for this project I have nothing to disclose OBJECTIVES Identify at
More informationJanuary 2017 Investor Presentation. confidently live life with ease
January 2017 Investor Presentation confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More informationCAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION
CAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS 2016 Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION September 9-11, 2016 ~ Sonesta Resort ~ Hilton Head Island, SC This continuing
More informationDIABETES & ENDOCRINE DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT
DIABETES TECHNOLOGY: HOW TO STAY CURRENT WITH ONGOING TECHNOLOGY ADVANCEMENT Min-Jye Chen, MD Endocrinology Diabetes Management of the School-Aged Child Provided by Texas Children s Hospital Provider #18-267764-A
More informationDIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson
DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson March 3 rd, 2018 Who is this guy? Accelerating Progress 1 Oh that guy! Accelerating Progress 2 STATE OF T1D CARE
More informationCGM and Closing The Loop
CGM and Closing The Loop Dualities Research: Helmsely Charitable Trust, ADA, JDRF, NIDDK Consulting: Abbott Diabetes Care, Roche, Intarcia, Valeritas, Adocia, Big Foot Like With Pumps, We ve Come A Long
More informationCowen Investor Conference March confidently live life with ease
Cowen Investor Conference March 2018 confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could
More informationMore Than 1 Year of Hybrid Closed Loop in Pediatrics. Gregory P. Forlenza, MD Assistant Professor Barbara Davis Center
More Than 1 Year of Hybrid Closed Loop in Pediatrics Gregory P. Forlenza, MD Assistant Professor Barbara Davis Center Disclosure Dr. Forlenza has served as a consultant for Abbott Diabetes Care and conducts
More informationObjectives. The Problem. We ve come a LONG way, Innovations in Diabetes Care and Management. Barbara Walz, RN, BSN, CDE April 26, 2018
Objectives Innovations in Diabetes Care and Management Barbara Walz, RN, BSN, CDE April 26, 2018 1. Briefly discuss the history of diabetes management over the past 100 years 2. Describe the impact of
More informationAdvances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?
Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures
More informationThe Realities of Technology in Type 1 Diabetes
The Realities of Technology in Type 1 Diabetes May 6, 2017 Rosanna Fiallo-scharer, MD Margaret Frederick, RN Disclosures I have no conflicts of interest to disclose I will discuss some unapproved treatments
More informationconfidently live life with ease Management Presentation
confidently live life with ease Management Presentation 1 Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that could cause
More informationWednesday, October 24, 2018 Pre-Conference "Women's Health Summit: Cardiometabolic Health Across the Lifespan"
Wednesday, October 24, 2018 Pre-Conference "Women's Health Summit: Cardiometabolic Health Across the Lifespan" Start End Session Faculty 11:00 AM 11:10 AM Introduction to CMHC Women's Health Summit Pamela
More informationAbbott FreeStyle Libre Pro System
Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationCanaccord Growth Conference August confidently live life with ease
Canaccord Growth Conference August 2018 confidently live life with ease Forward-Looking Statements This presentation contains forward-looking statements that are not purely historical regarding Senseonics
More informationAdvances Towards the Bionic Pancreas.
Advances Towards the Bionic Pancreas. Ron Brazg MD, FACE Rainier Clinical Research Center Renton, WA DISCLOSURES Rainier Clinical Research Center is an independent research facility not directly affiliated
More informationReduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home
Reduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home Richard M. Bergenstal 1, David C. Klonoff 2, Bruce W. Bode 3, Satish
More informationPatrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference
Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's
More informationNEWS BRIEFING Advances in Technology. moderated by: Irl Hirsch, MD University of Washington Medical Center
NEWS BRIEFING Advances in Technology moderated by: Irl Hirsch, MD University of Washington Medical Center 1 EMBARGO POLICY All recordings are for personal use only and not for rebroadcast online or in
More informationAdvances in Diabetes Technology Part II: Analysis of Diabetes Self Management Devices and Support Tools
Advances in Diabetes Technology Part II: Analysis of Diabetes Self Management Devices and Support Tools Jennifer Trujillo, PharmD, FCCP, BCPS, CDE, BC ADM Associate Professor University of Colorado School
More informationOBJECTIVES THE PAST INNOVATIVE TECHNOLOGY & DIABETES DIABETES MIS MANAGEMENT IMPROVEMENTS IN DIABETES MANAGEMENT
OBJECTIVES INNOVATIVE TECHNOLOGY & DIABETES TRISHA PORRETTI, RN, BSN, CDE PWD FOR 25 YEARS Identify important safety features and differences of 3 Continuous Glucose Monitoring (CGM) systems Identify important
More informationRebecca Newberry APRN MS CDE
Current Diabetes Medications Nursing Implications and Applications Rebecca Newberry APRN MS CDE Methodist Center for Diabetes and Nutritional Health Disclosures Objectives Speakers Bureaus/Consulting Board
More informationTechnology in Diabetes Care: Emerging Level
Technology in Diabetes Care: Emerging Level Charlotte Parsons ARNP, CDE Christine Fisher, RD, CD, CDE, CPT WADE April 26, 2019 Disclosures to Participants Notice of Requirements for Successful Completion:
More informationNEVADA CHAPTER OF THE
NEVADA CHAPTER OF THE AMERICAN ASSOCIATION OF CLINICAL E NDOCRINOLOGISTS 245 Riverside Avenue SUITE 200 Jacksonville, FL 32202 PHONE (904) 353-7878 FAX (904) 353-8185 OFFICERS Kenneth Izuora MD, MBA, FACE
More informationAbbott FreeStyle Libre Pro System
, the Professional CGM Abbott FreeStyle Libre Pro Reader Kit includes: Reader, USB cable, interactive tutorial on USB, and power adapter, user s manual, Quick Start Guide, Quick Reference Guide Kit includes:
More informationAnnual Stockholder Meeting May 30, confidently live life with ease
Annual Stockholder Meeting May 30, 2018 confidently live life with ease Forward-Looking Statements This presentation contains certain forward-looking statements that involve risks and uncertainties that
More informationAACE/ACE Consensus Conference on Glucose Monitoring: An Update
Can You Manage Diabetes Without Glucose Monitoring? Didn t Think So! George Grunberger, MD, FACP, FACE Chairman, Grunberger Diabetes Institute Clinical Professor, Internal Medicine and Molecular Medicine
More informationApproved by: Integrated Health Quality Management Subcommittee Effective Date: Department of Origin: Integrated Healthcare Services.
Reference #: MC/L008 Page: 1 of 8 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS)
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 05/24/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationCONTINUOUS GLUCOSE MONITORING SOLUTIONS Provided by Roche Diabetes Care
CONTINUOUS GLUCOSE MONITORING SOLUTIONS Provided by Roche Diabetes Care More confidence for your patients 03 GIVING YOU THE CHOICE CGM solutions provided by Roche Diabetes Care Welcome to a world of new
More informationCorporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
More informationINSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. Waterproof to a depth
More informationThe Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections
8/5/217 The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections Richard M. Bergenstal, MD Executive Director International Diabetes Center at Park Nicollet Minneapolis,
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, February 3, 2018 William A. Egan Civic
More informationThe Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes
The Growing Future of Diabetes: Insulin Pump Therapy in Type 1 and 2 Diabetes Sarah Dombrowski, PharmD, BCACP Pennsylvania Pharmacists Association 10/20/18 1 Objectives At the completion of this activity,
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 07/10/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, May 5, 2018 Hawaii Convention Center
More information10:20 AM March 5, B 100% 235 u. 124 mg/dl 3 HRS INSULIN ON BOARD:
DEXCOM G5 MOBILE CGM COMPATIBLE B 100% 235 u INSULIN ON BOARD: OPTIONS 10:20 AM March 5, 2017 400 350 300 250 200 150 100 50 1.1 u 1:09 hrs BOLUS 124 mg/dl 3 HRS The pump that gets updated, not outdated.
More informationDexcom Current and Future Technology Innovations. Jorge Valdes Chief Technical Officer
Dexcom Current and Future Technology Innovations 2015 Jorge Valdes Chief Technical Officer G5 App Sensor (Same as G4) Indicated for adults and children down to Age 2 years Tiny insertion needle (26Ga)
More informationPredicts and helps prevent lows with. zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY
Predicts and helps prevent lows with * zero fingersticks NOW FEATURING BASAL-IQ TECHNOLOGY Basal-IQ Technology is not a substitute for active self-management of your diabetes. Please see back cover for
More informationHow to Set Up a Diabetes Technology Practice in the Real World: Meaningful Monitoring Thoughtful Therapy Troubled Times
How to Set Up a Diabetes Technology Practice in the Real World: Meaningful Monitoring Thoughtful Therapy Troubled Times Timothy Bailey, MD, FACE, CPI Director of Interventional Endocrinology, AMCR Institute
More informationMEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps
POLICY: PG0177 ORIGINAL EFFECTIVE: 12/01/08 LAST REVIEW: 02/13/18 MEDICAL POLICY Continuous Glucose Monitoring Systems and Insulin Pumps GUIDELINES This policy does not certify benefits or authorization
More informationDiabetes and Technology. Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE
Diabetes and Technology Saturday, September 9, 2017 Aimee G sell, APRN, ANP-C, CDE Disclosure Speaker s Bureau: Janssan Pharmaceuticals Current Technology V-Go by Valeritas Continuous Sensors (personal
More informationTechnology in Diabetes Management Irl B. Hirsch, MD University of Washington
Technology in Diabetes Management 2016 Irl B. Hirsch, MD University of Washington Dualities Research: Helmsley Charitable Trust, JDRF, ADA, NIDDK, CDC Consulting: Abbott, Roche, Intarcia Raise Your Hand
More informationCONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID
FLUID Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationINSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. MORE TIME HERE TO USING
More informationEmerging Automated Insulin Delivery Systems
Emerging Automated Insulin Delivery Systems Richard M. Bergenstal, MD International Diabetes Center Park Nicollet & HealthPartners Minneapolis, MN Presenter Name 1 Dualities: Richard M. Bergenstal, MD
More informationBASICS OF INSULIN PUMPS. Jennifer Okemah MS RD BCADM CDE CSSD
BASICS OF INSULIN PUMPS Jennifer Okemah MS RD BCADM CDE CSSD SPEAKER DISCLOSURES: Contracted trainer for Animas, Omnipod, Medtronic Dexcom Advisory Board Sanofi Advisory Board Sanofi Contracted Speaker
More informationComparative table of insulin pumps
Comparative table of insulin pumps Pumps reviewed: insight (Roche Veo 640G Mylife OmniPod Mylife S () The first stop for professional medicines advice www.sps.nhs.uk Authored May 2018 Insight OmniPod S
More informationA Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes
11 TH YEAR IN A UNIQUE NATIONAL SERIES A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes MEDICAL EDUCATION FOR HEALTHCARE PROFESSIONALS Making the Connection Between Patients
More informationMichael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation
Michael L. Levitz Chief Financial Officer November 15, 2017 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationA New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation
691301DSTXXX10.1177/1932296817691301Journal of Diabetes Science and TechnologyChristiansen et al research-article2017 Original Article A New, Wireless-enabled Blood Glucose Monitoring System That Links
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, March 17, 2018 Monterey Conference
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm The Harvard community
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationFuture Direction of Artificial Pancreas. Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
Future Direction of Artificial Pancreas Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer,
More informationContinuous Glucose Monitoring
Continuous Glucose Monitoring Information about fully-subsidised continuous glucose monitoring for children and young people with type 1 diabetes Continuous glucose monitoring (CGM) can help in managing
More informationPatrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation
Patrick J. Sullivan Chief Executive Officer January 9, 2018 Investor Presentation Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's expectations, anticipations,
More informationUpdate on Diabetes Technology
Update on Diabetes Technology Andrew Ahmann, MD Professor of Medicine Director, Harold Schnitzer Diabetes Health Center OHSU Objectives: Recognize the growing role of technology in assisting patients and
More informationFAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication
FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication Q1. The Dexcom G5 Mobile System is the first CGM System to receive FDA approval
More informationENDOCRINOLOGY FOR PRIMARY CARE
ENDOCRINOLOGY FOR PRIMARY CARE Grand Cayman Islands, BWI The Westin Grand Cayman Seven Mile Beach Resort and Spa April 30 May 3, 2015 Participating Faculty Linda A. Barbour, MD, MSPH Professor of Medicine
More informationDiabetes Technology in Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA
Diabetes Technology in 2018 Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA Dualities Research: Medtronic Diabetes Consulting: Abbott Diabetes Care, BD, Bigfoot, Roche Let s First
More informationENDOCRINOLOGY FOR PRIMARY CARE
ENDOCRINOLOGY FOR PRIMARY CARE Las Vegas, Nevada The Cosmopolitan February 27 March 1, 2015 Participating Faculty Gregory A. Brent, MD Professor, Departments of Medicine and Physiology David Geffen School
More informationJDRF RESEARCH UPDATE. Daniel Finan, Ph.D. Research Director
JDRF RESEARCH UPDATE Daniel Finan, Ph.D. Research Director March 10, 2018 PRESENTER Daniel Finan Biomedical engineer B.S. Chemical Engineering University of Colorado, 2003 Ph.D. Chemical Engineering UC
More informationMaking the Connection Between Patients and Providers
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, April 27, 2019 Hawaii Convention Center
More informationDIABETES IS PRIMARY FROM THE JOURNALS. from the American Diabetes Association TREATMENTS + THERAPIES TIMELY NEWS AND NOTES FOR PRIMARY CARE PROVIDERS
DIABETES IS PRIMARY TIMELY NEWS AND NOTES FOR PRIMARY CARE PROVIDERS from the American Diabetes Association By Max Bingham, PhD FROM THE JOURNALS Self-Monitoring of Blood Glucose in Non Insulin-Treated
More informationState of California Health and Human Services Agency Department of Health Care Services
State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationWearable Devices for Heart Disease, Diabetes and Health
Wearable Devices for Heart Disease, Diabetes and Health Pam R. Taub MD, FACC Director of Step Family Cardiac Wellness and Rehabilitation Center Associate Professor of Medicine UC San Diego Health System
More informationNon-Invasive Glucose Monitoring. Kevin Walls April 12, :30 PM-7:30 PM.
Non-Invasive Glucose Monitoring Kevin Walls April 12, 2018 6:30 PM-7:30 PM. Technology is evolving Technology is evolving at such a rapid rate it s hard to keep up. Imagine living a healthier life without
More informationPeople with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT
Position Statement People with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT Diabetes Australia believes that people with diabetes should have choice and access
More information06/13/17. A. Completed a comprehensive diabetes education program within the past two years; and
Reference #: MC/L011 Page 1 of 4 PRODUCT APPLICATION: PreferredOne Community Health Plan (PCHP) PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA
More informationWearable Devices Emerging Strategies for Patient Management
Wearable Devices Emerging Strategies for Patient Management Pam R. Taub MD, FACC Director of Step Family Cardiac Wellness and Rehabilitation Center Associate Professor of Medicine UC San Diego Health System
More informationPump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine
Pump and Sensor Data Interpretation Irl B. Hirsch, MD University of Washington School of Medicine Dualities Research: Medtronic Diabetes Consulting: Abbott Diabetes Care, BD, Bigfoot, Roche Raise Your
More informationClinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham
Clinical News and Innovation in Type 1 Diabetes and Technology Parth Narendran University Hospitals Birmingham Adjunctive therapy to insulin Accurate diagnosis of T1D Early intensive treatment Technology
More informationCALIFORNIA CHAPTER OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS. Julie Cockley Director, AACE Chapters. Dear Prospective Exhibitors,
CALIFORNIA CHAPTER OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
More informationCOMPANY OVERVIEW. July 30, 2018
COMPANY OVERVIEW July 30, 2018 SAFE HARBOR & NON-GAAP FINANCIAL MEASURES Forward Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationBetter Diagnostics for Life
NASDAQ: NMRD Better Diagnostics for Life Interim Clinical Presentation sugarbeat 12 th September 2018 A Prospective Single Centre Evaluation of the Accuracy and safety of the sugarbeat Non-invasive Continuous
More informationNEWS BRIEFING Diabetes and Cardiovascular Disease. Moderated by: Robert Eckel, MD University of Colorado
NEWS BRIEFING Diabetes and Cardiovascular Disease Moderated by: Robert Eckel, MD University of Colorado 1 EMBARGO POLICY All recordings are for personal use only and not for rebroadcast online or in any
More informationCompany Overview February 26, 2019
Company Overview February 26, 2019 SAFE HARBOR Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More informationInterpretation of Continuous Glucose Monitoring (CGM) Data
Interpretation of Continuous Glucose Monitoring (CGM) Data Sherri Horvat, BSN, RN, CDE Blood Glucose Manager, Animas Corporation A Johnson & Johnson Diabetes Care Company Overview of CGM Continuous glucose
More informationPCSK9 Inhibitors and Modulators
PCSK9 Inhibitors and Modulators Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Disclosures Speaker s
More informationUpdates in Diabetes Technology
Updates in Diabetes Technology Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO No disclosures Disclosures 1 Objectives Distinguish patients appropriate for continuous glucose monitoring and insulin
More informationGLOOKO DREAMED FOR ANDROID USER GUIDE
GLOOKO DREAMED FOR ANDROID USER GUIDE November 2018 IFU-0017 02 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Glooko Intended Use... 2 Dreamed Intended Use... 2
More informationContinuous Glucose Monitors for Diabetes Management
Continuous Glucose Monitors for Diabetes Management Ryan Huang, DO PGY II, Sonia Garcia-Jayne, DO PGY II Mandeep Gill, DO PGY I, Justin Leeka, DO, PGY I, Catherine Nguyen OMS IV Family Medicine Residency,
More informationDIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT
DIABETES TECHNOLOGY: ENDLESS CHOICES FOR HEALTHY MANAGEMENT MAKING THE MOST OF MODERN DIABETES TREATMENTS & TECHNOLOGIES JENNIFER C. SMITH RD, LD, CDE DIRECTOR OF LIFESTYLE AND NUTRITION INTEGRATED DIABETES
More informationNEWS BRIEFING Adjunctive Therapies in Type 1 and Type 2 Diabetes
NEWS BRIEFING Adjunctive Therapies in Type 1 and Type 2 Diabetes Moderated by: Bernard Zinman, MD, CM, FRCPC, FACP Lunenfeld-Tanenbaum Research Institute and University of Toronto Mount Sinai Hospital
More informationDIABETES: WHAT S NEW? WHAT S NEXT? Saturday, October 27, a.m. 2:45 p.m. MARY & DICK ALLEN DIABETES CENTER PRESENTS:
MARY & DICK ALLEN DIABETES CENTER PRESENTS: DIABETES: WHAT S NEW? WHAT S NEXT? Saturday, October 27, 2018 8 a.m. 2:45 p.m. Arnold and Mabel Beckman Center of the National Academies of Sciences & Engineering
More informationThe In-Clinic Close Loop Experience in the US
The In-Clinic Close Loop Experience in the US Keystone Symposium, Practical Ways to Achieve Targets in Diabetes Care July 14, 2012 Francine Ratner Kaufman, MD Chief Medical Officer, VP Global Medical,
More informationWHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE
WHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE MAY 5, 2018 OBJECTIVES Strong understanding of diabetes and its management
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM
ADVANCES IN DIABETES TECHNOLOGY: A FOCUS ON CONTINUOUS GLUCOSE MONITORING 9:15 10:15 AM ACPE UAN: 0107-9999-18-124-L01-P 0.1 CEU/1 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:
More informationGuidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AMERICAN COLLEGE OF ENDOCRINOLOGY Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease Writing Committee Chair: Paul S. Jellinger,
More informationCOMPANY OVERVIEW. April 26, 2018
COMPANY OVERVIEW April 26, 2018 SAFE HARBOR & NON-GAAP FINANCIAL MEASURES Forward Looking Statements Certain statements in this presentation constitute forward-looking statements, including, without limitation,
More information